NEW YORK (TheStreet) -- CHANGE IN RATINGS:
Advance Auto Parts AAP upgraded at JP Morgan to overweight, JP Morgan said. Company can gain market share in an industry that's likely to see a soft landing in 2013.
Aecom ACM upgraded at BofA/Merrill from underperform to buy, Bank of America/Merrill Lynch said. $35 price target. Company is seeing a solid recovery in free cash flow.
Activision Blizzard ATVI upgraded at Sterne Agee from neutral to buy, Sterne Agee said. $17 price target. Company is positioned well for the next business cycle and the company will likely buy back a significant amount of shares.
Biogen Idec BIIB upgraded at Citigroup to buy from neutral, Citigroup said. $187 price target. Expecting a solid Tecfidera launch.
Celgene CELG rated new outperform at JMP. $130 price target. Company is a market leader and can continue to deliver solid growth.
Discover DFS upgraded at Credit Suisse from neutral to outperform, Credit Suisse said. $47 price target. Company can deliver the best growth in the industry at the lowest valuation.
DSW DSW rated new buy at Sterne Agee. $75 price target. Company is a market leader and can deliver above-average growth for the foreseeable future.
Guess GES upgraded at Wedbush from neutral to outperform, Wedbush said. $34 price target. There are early signs that the business is turning around in North America.
Gartner IT downgraded at Piper from overweight to neutral, Piper Jaffray said. Valuation call, based on a $52 price target.
Annaly Capital NLY upgraded at Sterne Agee from underperform to neutral, Sterne Agee said. Valuation call, based on a $14.25 price target.
Nuance NUAN downgraded at Needham from buy to hold, Needham said. Company is seeing lower international sales and demand from healthcare customers.
MetroPCS PCS upgraded at Nomura from reduce to neutral, Nomura said. $9.50 price target. Worst news appears to be behind the company.
Riverbed RVBD downgraded at FBR from outperform to market perform, FBR Capital Markets said. $20 price target. Company is seeing lower core sales.
Riverbed downgraded at Cantor from buy to hold, Cantor Fitzgerald said. $20 price target. Core products are showing little growth.
Teva TEVA downgraded at Canaccord to hold, Canaccord Genuity said. $45 price target. Company turnaround is taking longer than expected.
Trinity Industries TRN downgraded at UBS to neutral from buy, UBS said. $41 price target. Continued growth in tank car orders increasingly challenging.
Westlake Chemical WLK upgraded at UBS to neutral from sell, UBS said. $90 price target. Softer ethane pricing outlook.
STOCK COMMENTS / EPS CHANGES
Biogen Idec BIIB numbers increased at Credit Suisse. BIIB estimates were raised through 2016, Credit Suisse said. Tysabri deal should add to earnings. Outperform rating and new $185 price target.
Cigna CI numbers raised at Jefferies. Shares of CI now seen reaching $71, Jefferies said. Estimates also raised on its upward 2013 revision. Buy rating.
Cisco CSCO target raised at Citigroup to $24, Citigroup said. Continued execution in an improving macro environment. Buy rating.
Coinstar CSTR estimates, target cut at JP Morgan. CSTR estimates were reduced through 2014, JP Morgan said. Company is seeing lower sales. Neutral rating and new $51 price target.
Eastman Chemical EMN target raised at Jefferies. Shares of EMN now seen reaching $79, Jefferies said. Favorable pricing in 2013. Hold rating.
Google GOOG added to Best Ideas List at Morgan Stanley. Company can deliver 15% compound annual free cash flow growth over the next five years. $932 price target.
CarMax KMX numbers raised at Oppenheimer. Shares of KMX now seen reaching $46, Oppenheimer said. Estimates also raised on attractive market share growth. Outperform rating.
LinkedIn LNKD estimates, target raised at BMO. Shares of LNKD now seen reaching $130, according to BMO Capital. Estimates also increased, as new products are driving growth. Market Perform rating.
Microchip Technology MCHP numbers raised at Jefferies. Shares of MCHP now seen reaching $41, Jefferies said. Estimates also raised on fourth quarter beat. Buy rating.
Microchip estimates, target raised at Credit Suisse. Shares of MCHP now seen reaching $40, according to Credit Suisse. Estimates also increased, as the company is seeing higher core demand and benefits from acquisitions. Outperform rating.
Martin Marietta MLM numbers raised at Jefferies. Shares of MLM now seen reaching $114, Jefferies said. Estimates also raised stronger demand enabling fourth quarter beat. Buy rating.
NCR NCR estimates, target boosted at JP Morgan. Shares of NCR now seen reaching $37, according to JP Morgan. Estimates also upped, given the company's new guidance. Overweight rating.
OpenTable OPEN numbers lowered at Oppenheimer. Shares of OPEN now seen reaching $49, Oppenheimer said. Estimates also lowered on slowing earnings growth. Perform rating.
>To submit a news tip, email: email@example.com.
READERS ALSO LIKE:
- Google vs. Apple: A Tale of Two Companies
- 5 Tax Tips You May Be Forgetting
- Jim Cramer: 10 Stock Picks for 2013 (Updated With Videos)